X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.businesswire.com/news/home/20210308005285/en/ImmunityBio-and-NantKwest-Begin-Dosing-Participants-in-Global-Trials-for-Novel-COVID-19-Vaccine-Subcutaneous-Route-in-South-Africa-Oral-and-Sublingual-in-the-U.S.
https://www.businesswire.com/news/home/20210211005960/en/ImmunityBio-and-NantKwest-Announce-FDA-Authorization-to-Study-hAd5-T-Cell-COVID-19-Vaccine-for-Combination-of-Subcutaneous-Oral-and-Sublingual-Boost-to-Induce-T-Cell-Mucosal-and-Antibody-Immunity
https://nantkwest.com/nantkwest-immunitybio-announce-positive-interim-data-on-survival-rates-in-metastatic-pancreatic-cancer-trials/
https://www.businesswire.com/news/home/20201222005352/en/CytRx-Comments-on-Proposed-Combination-of-ImmunityBio-and-NantKwest
https://www.businesswire.com/news/home/20201222005352/en/CytRx-Comments-on-Proposed-Combination-of-ImmunityBio-and-NantKwest
https://www.fiercebiotech.com/biotech/2-nants-become-1-as-soon-shiong-combines-nantkwest-immunitybio
https://nantkwest.com/immunitybio-nantkwest-announce-positive-interim-phase-1-safety-data-of-had5-covid-19-vaccine-dose-study/
https://endpts.com/patrick-soon-shiong-steps-down-as-ceo-of-nantkwest-a-linchpin-of-his-cancer-moonshot/
Market Place
Share 
